|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| G01N 33/50 | |||
| A61P 37/00 | |||
| A61P 1/00 | |||
| G01N 33/68 |
| (11) | Patento numeris | 3256145 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16748828.7 |
| Europos patento paraiškos padavimo data | 2016-02-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2016/050146 |
| Data | 2016-02-09 |
| (87) | Numeris | WO 2016/128966 |
| Data | 2016-08-18 |
| (30) | Numeris | Data | Šalis |
| 201562114086 P | 2015-02-10 | US |
| (72) |
VADASZ, Zahava, IL
TOUBI, Elias, IL
|
| (73) |
The Fund for Medical Research, Development of Infrastructure and Health Services - Bnai Zion Medical Center,
47 Golomb Street, 31048 Haifa,
IL
|
| (54) | SEMAPHORIN 3A FOR TREATMENT AND ASSESSMENT OF SEVERITY OF INFLAMMATORY BOWEL DISEASE |
| SEMAPHORIN 3A FOR TREATMENT AND ASSESSMENT OF SEVERITY OF INFLAMMATORY BOWEL DISEASE |